| abstract |
This invention relates to MTP / Apo-B secretion inhibitors of formula (I), wherein RR, X, m and n are as defined in the description of the invention, as well as pharmaceutical compositions containing these compounds, and methods of using these compounds and compositions. The compounds of the invention are useful in the treatment of obesity and associated diseases, conditions or disorders. |